Financial Contrast: Icon (NASDAQ:ICLR) versus Aeon Global Health (OTCMKTS:AGHC)

Aeon Global Health (OTCMKTS:AGHC) and Icon (NASDAQ:ICLR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Profitability

This table compares Aeon Global Health and Icon’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aeon Global Health	N/A	N/A	N/A
Icon	7.40%	10.58%	6.01%

Insider & Institutional Ownership

95.6% of Icon shares are owned by institutional investors. 11.5% of Aeon Global Health shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and target prices for Aeon Global Health and Icon, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aeon Global Health	0	0	0	0	0.00
Icon	3	7	7	0	2.24

Icon has a consensus price target of $148.80, suggesting a potential upside of 30.31%. Given Icon’s stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Aeon Global Health.

Valuation and Earnings

This table compares Aeon Global Health and Icon”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aeon Global Health	N/A	N/A	N/A	N/A	N/A
Icon	$8.28 billion	1.11	$791.47 million	$7.39	15.45

Icon has higher revenue and earnings than Aeon Global Health.

Summary

Icon beats Aeon Global Health on 9 of the 9 factors compared between the two stocks.

About Aeon Global Health

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.

About Icon

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.